CCL2 antibody (AA 24-99)
Quick Overview for CCL2 antibody (AA 24-99) (ABIN6989097)
Target
See all CCL2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 24-99
-
Cross-Reactivity
- Mouse, Rat
-
Predicted Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MCP1
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
Alternative Name
- MCP1
-
Background
-
Synonyms: MCP-1, monocyte chemotactic protein 1, CCL 2, CCL2, Chemokine C C motif ligand 2, Chemokine CC Motif Ligand 2, GDCF 2, GDCF 2 HC11, GDCF2, HC11, HSMCR30, JE, MCAF, MCP 1, MGC9434, Monocyte chemoattractant protein 1, Monocyte chemotactic and activating factor, Monocyte chemotactic protein 1, Monocyte secretory protein JE, SCYA2, Small inducible cytokine A2, Small inducible cytokine subfamily A Cys Cys member 2, SMC CF, SMCCF.
Background: Chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. Augments monocyte anti-tumor activity. Has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.
-
Gene ID
- 6347
-
UniProt
- P13500
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-